Innovative Clinical Trial Targets Recurrent BK Infection in Kidney Transplant Recipients

Loading
56920login-checkInnovative Clinical Trial Targets Recurrent BK Infection in Kidney Transplant Recipients

Kidney transplant patients like Tessa Adolph, from Rockford, Illinois, face an age-old problem to protect their new kidney and bodies after transplant surgery: how to prevent infections while also safeguarding their new kidney from damage or rejection.

In Adolph’s case, the risk came from the BK virus.

At 19, she was diagnosed with Henoch-Schönlein purpura, a rare condition that causes small blood vessels in the body organs, including kidneys, to become inflamed and bleed. This transitioned into a condition called IgA nephropathy, or Berger’s disease, that over time can cause kidney scarring and eventual kidney failure, she said. Read the full article from UW School of Medicine and Public Health.


569210login-checkInnovative Clinical Trial Targets Recurrent BK Infection in Kidney Transplant Recipients
Loading

Leave a Reply